scispace - formally typeset
P

Patrick Ip

Researcher at University of Hong Kong

Publications -  274
Citations -  6022

Patrick Ip is an academic researcher from University of Hong Kong. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 31, co-authored 197 publications receiving 3806 citations. Previous affiliations of Patrick Ip include Grantham Hospital & Queen Mary University of London.

Papers
More filters
Journal ArticleDOI

The Impact of a Health Empowerment Program on Self-Care Enablement and Mental Health among Low-Income Families: Evidence from a 5 Year Cohort Study in Hong Kong

TL;DR: In this paper , the authors evaluated the 5-year impact of a health empowerment program on health outcomes among adults from low-income families, and found that the intervention group demonstrated significantly greater increases in all items and total scores for the PEI-2 (all B > 0.59, p < 0.001), greater decreases in the DASS depression score (B = −1.98 p = 0.027) than the comparison group.
Journal ArticleDOI

A Data-Driven Context-Aware Health Inference System for Children during School Closures

TL;DR: Wang et al. as discussed by the authors investigated the impact of school closures on six health indicators, including physical activity intensity, physical functioning, self-rated health, psychosocial functioning, resilience, and connectedness.
Journal ArticleDOI

Changing Patterns of Intimate Partner Violence against Pregnant Women: A Three-Year Longitudinal Study

TL;DR: In this article , the authors provide longitudinal evidence regarding how pregnant women's exposure to intimate partner violence changes over time and examine the risk and protective factors associated with these changes, highlighting the importance of identifying different IPV types over time to provide targeted intervention to the most vulnerable groups.
Journal ArticleDOI

Benefits v. risks of COVID-19 vaccination: an examination of vaccination policy impact on the occurrence of myocarditis and pericarditis

TL;DR: Hong Kong implemented a single dose mRNA COVID-19 vaccine policy on September 15, 2021 for adolescents (age 12-17 years) as discussed by the authors , and there were no cases of carditis.